NCT06260813

Brief Summary

Posterior tibial tendon dysfunction (PTTD) is a progressive condition of the tendon of the tibialis posterior muscle with symptoms of tendinopathy or even rupture. Functionally, it is associated with the inability to lock the mid foot and thus manifests itself as a main contributor to adult acquired flatfoot deformity. Concerning treatment, clinical decision making is currently based on a classification integrating various parameters as pain, flexibility of the foot joints, the condition of the posterior tibial tendon assessed through ultrasound imaging and radiographic assessment of arthritic changes. Surprisingly, this classification does not consider any morphologic characteristics (the shape of a bone or joint) or functional, biomechanical characteristics of the foot and ankle, i.e. based on kinematics (e.g. range of motion) and/or kinetics (center of pressure, angular velocity, moment, power absorption and power generation of a joint). Detailed biomechanical characteristics of the foot and ankle can be reliably collected by instrumented gait analysis wherein a 3D camera system is combined with a force plate and plantar pressure platform. Kinematic studies in the field of PTTD typically considered the foot as a structure consisting of three segments: hind foot, forefoot and hallux. Consequently, the mid foot segment (the Chopart and Lisfranc joints) has been neglected, although it is this segment that is particularly affected in PTTD patients. The aim of this research is to overcome the limitations of the current classification system and treatment of PTTD patients, by complementing the current standard-of-care clinical assessment with better insight in the pathologic changes that occur in PTTD patients.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
27mo left

Started Aug 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress62%
Aug 2022Aug 2028

Study Start

First participant enrolled

August 22, 2022

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

December 8, 2023

Completed
2 months until next milestone

First Posted

Study publicly available on registry

February 15, 2024

Completed
4.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2028

Last Updated

April 15, 2025

Status Verified

April 1, 2025

Enrollment Period

5.9 years

First QC Date

December 8, 2023

Last Update Submit

April 10, 2025

Conditions

Outcome Measures

Primary Outcomes (7)

  • Kinematic characteristics during Gait analysis

    Range of Motion (ROM) of PTTD patient of each stage will be obtained and compared between the patient groups (PTTD 1-2-3) and a control group.

    1 year

  • Center of pressure during Gait analysis

    The center of pressure (kinetic characteristic) of PTTD patients of each stage will be obtained and compared between the patient groups (PTTD 1-2-3) and a control group. This information can be reliably collected by instrumented gait analysis wherein a 3D camera system is combined with a force plate and plantar pressure platform.

    1 year

  • Angular velocity during Gait analysis

    The angular velocity (kinetic characteristic) of PTTD patients of each stage will be obtained and compared between the patient groups (PTTD 1-2-3) and a control group. This information can be reliably collected by instrumented gait analysis wherein a 3D camera system is combined with a force plate and plantar pressure platform.

    1 year

  • Moment during Gait analysis

    The moment (kinetic characteristic) of PTTD patients of each stage will be obtained and compared between the patient groups (PTTD 1-2-3) and a control group. This information can be reliably collected by instrumented gait analysis wherein a 3D camera system is combined with a force plate and plantar pressure platform.

    1 year

  • Power absorption during Gait analysis

    The power absorption (kinetic characteristic) of PTTD patients of each stage will be obtained and compared between the patient groups (PTTD 1-2-3) and a control group. This information can be reliably collected by instrumented gait analysis wherein a 3D camera system is combined with a force plate and plantar pressure platform.

    1 year

  • Power generation during Gait analysis

    The power generation (kinetic characteristic) of PTTD patients of each stage will be obtained and compared between the patient groups (PTTD 1-2-3) and a control group. This information can be reliably collected by instrumented gait analysis wherein a 3D camera system is combined with a force plate and plantar pressure platform.

    1 year

  • Bone morphology

    Morphological characteristics of PTTD patients of each stage will be obtained by CT-scan and statistical shape modeling and compared between the study groups and a control group.

    1 year

Secondary Outcomes (5)

  • American Orthopaedic Foot & Ankle Society (AOFAS) score

    1 year

  • European Foot and Ankle Society (EFAS) score

    1 year

  • 36-item Short Form Health Survey (SF36)

    1 year

  • Visual Analogue Scale (VAS) pain

    1 year

  • Visual Analogue Scale (VAS) satisfaction

    1 year

Study Arms (2)

PTTD patients (PTTD I, II and III)

EXPERIMENTAL

75 patients with PTTD (25 patients in Stage I, 25 patients in Stage II, 25 patients in Stage III)

Diagnostic Test: RadiographyDiagnostic Test: UltrasoundDiagnostic Test: MRIDiagnostic Test: CT-scanDiagnostic Test: Gait analysis

Healthy control group

EXPERIMENTAL

25 healthy volunteers

Diagnostic Test: RadiographyDiagnostic Test: CT-scanDiagnostic Test: Gait analysis

Interventions

RadiographyDIAGNOSTIC_TEST

X-rays of the ankle; anterior-posterior, lateral, Mortise view and hindfoot alignment view. Standard weight bearing x-rays of the foot; anterior-posterior, lateral and oblique view.

Healthy control groupPTTD patients (PTTD I, II and III)
UltrasoundDIAGNOSTIC_TEST

Ultrasound of the posterior tibial tendon to see if there is an irritation, elongation or rupture.

PTTD patients (PTTD I, II and III)
MRIDIAGNOSTIC_TEST

MRI when ultrasound is not conclusive to identify an irritation, elongation or rupture of the posterior tibial tendon.

PTTD patients (PTTD I, II and III)
CT-scanDIAGNOSTIC_TEST

CT-scan to identify arthritis of the tibial-talar, subtalar and/or Chopart joints.

Healthy control groupPTTD patients (PTTD I, II and III)
Gait analysisDIAGNOSTIC_TEST

This lab is equipped with a 10-meter walkway surrounded by a passive optoelectronic motion analysis system consisting of 10 cameras to track the motion of markers. In the middle of the walkway, a force plate is integrated, with a pressure plate placed on top.

Healthy control groupPTTD patients (PTTD I, II and III)

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient groups:
  • Posterior tibial tendon dysfunction (all clinical stages)
  • Age 18-675 year
  • ICF obtained
  • Control group:
  • No pain complaints
  • No pes plano valgus, PTTD or pes cavo varus or other foot and ankle pathology
  • Age 18-75 year
  • ICF obtained

You may not qualify if:

  • Being younger than 18 years
  • Inability to walk without mobility aids
  • Inability to walk \< 100 meter
  • Difference in leg length \> 3cm
  • Subjects with BMI\>30 kg/m², due to less accurate gait analysis by absence of anatomical landmarks
  • Subjects unable to perform a gait analysis
  • Any medical condition possibly affecting normal gait.
  • Pregnancy: at the start or during the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UZ Leuven

Leuven, Vlaams-Brabant, 3000, Belgium

RECRUITING

MeSH Terms

Conditions

Posterior Tibial Tendon Dysfunction

Interventions

RadiographyUltrasonographyTomography, X-Ray ComputedGait Analysis

Condition Hierarchy (Ancestors)

Foot DiseasesMusculoskeletal Diseases

Intervention Hierarchy (Ancestors)

Diagnostic ImagingDiagnostic Techniques and ProceduresDiagnosisImage Interpretation, Computer-AssistedRadiographic Image EnhancementImage EnhancementPhotographyTomography, X-RayTomographyGaitPhysical ExaminationPhysical Functional PerformancePhysical FitnessHealthPopulation Characteristics

Study Officials

  • Sander Wuite

    Universitaire Ziekenhuizen KU Leuven

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
PTTD patients (PTTD I, II and III) and a healthy control group.
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Model Details: Prospective interventional study that includes PTTD patients (PTTD I, II and III) and a healthy control group.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 8, 2023

First Posted

February 15, 2024

Study Start

August 22, 2022

Primary Completion (Estimated)

August 1, 2028

Study Completion (Estimated)

August 1, 2028

Last Updated

April 15, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share

Locations